Switch to
More onapp

BDH Industries Ltd

BDH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹93 cr, stock is ranked 2,241
High RiskStock is 3.12x as volatile as Nifty
167.404.15 (+2.54%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹93 cr, stock is ranked 2,241
High RiskStock is 3.12x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
13.04
PB RatioPB Ratio
1.93
Dividend YieldDiv. Yield
2.21%
Sector PESector PE
35.84
Sector PBSector PB
4.35
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

BDH Industries Limited is engaged in the manufacturing of pharmaceuticals. It is also involved in the manufacturing of therapeutic formulations. It offers a range of oral solid dosages (OSD) technologies. It offers its products in various therapeutic classes, such as antifungal, antibiotics, anticancer, anti-diabetic, antidepressant, anti-ulcerant, antimalarial, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, non-steroidal anti-inflammatory drugs, psychotropic, trichology, and vitamins and minerals. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its specialty formulations include Morphine Sulphate Slow Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, and Indomethacin Extended Release Capsules U.S.P. 75 mg.

Financial TrendFinancial statements 

201920202021202252.5860.2858.7570.724.835.966.357.21
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Cash Dividend 
Ex. DateAug 12, 2022

Final • Div/Share: ₹ 3.6

Cash Dividend 
Ex. DateAug 17, 2021

Final • Div/Share: ₹ 3

Cash Dividend 
Ex. DateAug 19, 2020

Final • Div/Share: ₹ 2.5

See all events